Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
21.21
+0.19 (0.90%)
Dec 20, 2024, 4:00 PM EST - Market closed
Avantor Revenue
Avantor had revenue of $1.71B in the quarter ending September 30, 2024, a decrease of -0.34%. This brings the company's revenue in the last twelve months to $6.82B, down -3.12% year-over-year. In the year 2023, Avantor had annual revenue of $6.97B, down -7.26%.
Revenue (ttm)
$6.82B
Revenue Growth
-3.12%
P/S Ratio
2.11
Revenue / Employee
$900,898
Employees
7,570
Market Cap
14.44B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG | 21.46B |
Baxter International | 15.06B |
Viatris | 15.05B |
Moderna | 5.08B |
Hologic | 4.03B |
Align Technology | 3.96B |
Revvity | 2.72B |
Royalty Pharma | 2.27B |
AVTR News
- 3 days ago - Avantor: Durable FCF Generator Trading For Cheap - Seeking Alpha
- 4 weeks ago - Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference - PRNewsWire
- 4 weeks ago - Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology - Business Wire
- 5 weeks ago - Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges - PRNewsWire
- 6 weeks ago - Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors - PRNewsWire
- 2 months ago - Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Avantor® Reports Third Quarter 2024 Results - PRNewsWire
- 2 months ago - Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges - PRNewsWire